IBD
Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease
Feature
Noninvasive Assessment to Identify Patients With At-Risk Metabolic Dysfunction-Associated Steatohepatitis
Abstract: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease, is a major global health issue and a leading cause of chronic liver […]
From Recent Issues
Feature
Noninvasive Assessment to Identify Patients With At-Risk Metabolic Dysfunction-Associated Steatohepatitis
Abstract: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease, is a major global health issue and a leading cause of chronic liver […]
Feature
Alcohol Use Disorder and Alcohol-Associated Liver Disease: New Definitions, Screening, and Treatment
Abstract: Alcohol-associated liver disease (ALD) poses a significant global health burden and is a leading cause of liver-related morbidity and mortality. ALD encompasses a spectrum of […]
Feature
Rationale for an Eosinophilic Esophagitis Treat-to-Target Concept
Abstract: Eosinophilic esophagitis (EoE) is a chronic T helper 2–mediated inflammatory disorder of the esophagus defined clinically by the presence of symptoms of esophageal dysfunction and […]
Supplements
Highlights in Crohn’s Disease From Digestive Disease Week 2024
A Review of Selected Presentations From DDW 2024 May 18-21, 2024 • Washington, DC Upadacitinib Treatment Is Associated With Improved Clinical and Quality of Life Outcomes […]
Highlights in Ulcerative Colitis From Digestive Disease Week 2024
A Review of Selected Presentations From DDW 2024 May 18-21, 2024 • Washington, DC Extended Induction Response Over Time in Patients With Moderately to Severely Active […]
Highlights in IBS-C From Digestive Disease Week 2024
A Review of Selected Posters and CME Symposium From DDW 2024 May 18-21, 2024 • Washington, DC Efficacy of Tenapanor in Patients With IBS-C: A Post […]